Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Questions › Cardiology

Is left atrial appendage occlusion better than warfarin for Nonvalvular Atrial Fibrillation mortality?

high confidence  ·  Last reviewed July 1, 2026

For people with nonvalvular atrial fibrillation (AF), preventing strokes is a top priority. Warfarin has been a standard treatment, but newer options like left atrial appendage occlusion (LAAO) and direct oral anticoagulants (NOACs) are now available. Research suggests that LAAO may offer a survival advantage over warfarin, with a lower risk of death from any cause. This answer looks at what the evidence says about LAAO compared to warfarin for mortality.

What the research says

A network meta-analysis of 12 studies (including 8 randomized trials) found that warfarin was associated with higher all-cause mortality compared to LAAO (odds ratio 1.44, meaning about 44% higher odds of death) 2. The same analysis also showed that NOACs (both standard-dose and low-dose) were superior to warfarin for mortality 2. Another network meta-analysis of 10 randomized trials confirmed that both LAAO and NOACs reduced the risk of hemorrhagic stroke compared to warfarin, and both were superior to warfarin for net adverse clinical events, with no significant difference between LAAO and NOACs 6. A separate meta-analysis of 16 studies found that LAAO reduced the risk of stroke compared to warfarin (relative risk 0.65) 9. While LAAO appears to be a reasonable alternative, it is important to note that device deployment is not always successful (failure in about 6% of cases) and complications occur in about 7% of procedures 9. Overall, the evidence suggests that LAAO is at least as good as warfarin for preventing death and stroke, with a lower bleeding risk 269.

What to ask your doctor

  • Based on my CHA2DS2-VASc score and bleeding risk, is LAAO a reasonable option for me compared to warfarin or a NOAC?
  • What are the specific risks of the LAAO procedure, including the chance of device failure or complications?
  • If I choose LAAO, will I still need to take blood thinners for a period after the procedure?
  • How does the long-term mortality benefit of LAAO compare to NOACs in my case?
  • Are there any specific factors (like kidney function or other health conditions) that would make one option better for me?

This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.